• Media type: E-Article
  • Title: mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
  • Contributor: Weiler, Markus; Blaes, Jonas; Pusch, Stefan; Sahm, Felix; Czabanka, Marcus; Luger, Sebastian; Bunse, Lukas; Solecki, Gergely; Eichwald, Viktoria; Jugold, Manfred; Hodecker, Sibylle; Osswald, Matthias; Meisner, Christoph; Hielscher, Thomas; Rübmann, Petra; Pfenning, Philipp-Niklas; Ronellenfitsch, Michael; Kempf, Tore; Schnölzer, Martina; Abdollahi, Amir; Lang, Florian; Bendszus, Martin; von Deimling, Andreas; Winkler, Frank; [...]
  • imprint: Proceedings of the National Academy of Sciences, 2014
  • Published in: Proceedings of the National Academy of Sciences
  • Language: English
  • DOI: 10.1073/pnas.1314469111
  • ISSN: 0027-8424; 1091-6490
  • Origination:
  • Footnote:
  • Description: <jats:title>Significance</jats:title> <jats:p> <jats:italic>N</jats:italic> -myc downstream regulated gene 1 (NDRG1) is a central and druggable molecular hub integrating diverse therapy-induced microenvironmental factors to promote resistance toward alkylating chemotherapy. We suggest that NDRG1-mediated chemoprotection is achieved via binding and stabilizing methyltransferases, such as O <jats:sup>6</jats:sup> -methylguanine-DNA methyltransferase. </jats:p>
  • Access State: Open Access